Aarti Ind Call

Aarti Industries

                          BSE: 524208 | NSE: AARTIIND | ISIN: INE769A01020 | SECTOR: CHEMICALS

**Medium Term Call**

Medium Term Call; 17-03-2015 , Investors with risk appetite looking for quick bucks can now buy Aarti Industries

(Medium Term)@345-325 

sl 300 

tgt1 428 

tgt2 450 !!

ABOUT AARTI INDUSTRIES :

Aarti Ind is in the Chemicals sector. The current market capitalisation stands at Rs 3,296.05 crore.The company has reported a standalone sales of Rs 681.33 crore and a Net Profit of Rs 42.89 crore for the quarter ended Dec 2014.

The company management includes Chandrakant V Gogri - Chairman Emeritus, Rajendra V Gogri - Chairman & Managing Director, Shantilal T Shah - Vice Chairman, Parimal H Desai - Whole Time Director, Manoj M Chheda - Whole Time Director, Hetal Gogri Gala - Whole Time Director, Kirit R Mehta - Whole Time Director, Renil R Gogri - Whole Time Director, Ramdas M Gandhi - Independent Director, Laxmichand K Jain - Independent Director, Vijay H Patil - Independent Director, K V S Shyam Sunder - Independent Director, P A Sethi - Independent Director, Bhavesh R Vora - Independent Director, Rashesh C Gogri - Vice Chairman & Mng.Director. 

It is listed on the BSE with a BSE Code of 524208 and the NSE with an NSE Code of AARTIIND.

Its Registered office is at Plot Nos. 801, 801/23, GIDC Estate, Phase III,, Vapi,Gujarat - 396195.

Their Registrars are Sharepro Services (India) Pvt.Ltd.

Company Information :- 

REGISTERED OFFICE :-

Address

Plot Nos. 801, 801/23, GIDC Estate, Phase III,,

City

Vapi

State

Gujarat

Pin Code

396195

Tel. No.

Fax No.

02638-

Email:

investorrelations@aartigroup.com

Internet

http://www.aartigroup.com

REGISTRARS :-

Name

Sharepro Services (India) Pvt.Ltd.

Address

13 AB, Samhita Warehousing Complex, 2nd Floor, Sakinaka Telephone Exchange Lane, Off Andheri-Kurla Road, Sakinaka, Andheri (E)

City

Mumbai - 400072

State

Maharashtra

Tel. No.

022-67720300, 67720400

Fax No.

022-28591568, 28508927

Email:

sharepro@shareproservices.com

Internet

http://www.shareproservices.com

MANAGEMENT :-

Name

Designation

Chandrakant V Gogri

Chairman Emeritus

Rajendra V Gogri

Chairman & Managing Director

Shantilal T Shah

Vice Chairman

Parimal H Desai

Whole Time Director

Manoj M Chheda

Whole Time Director

Orchid Chem Call

Orchid Chemicals and Pharmaceuticals

        BSE: 524372 | NSE: ORCHIDCHEM | ISIN: INE191A01019 | SECTOR: PHARMACEUTICALS

**Medium Term Call**

Medium term call- 12-03-2015; investors with risk appetite looking for quick bucks can now buy Orchid Chemicals 

( Medium term)@62.85-60 sl 49 

 tgt1 97 

tgt2 112 

tgt3 120!!

ABOUT ORCHID CHEMICAL :

Orchid Chemical is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 529.05 crore.The company has reported a standalone sales of Rs 159.02 crore and a Net Loss of Rs -120.09 crore for the quarter ended Dec 2014.

The company management includes K Raghavendra Rao - Managing Director, K N Venkatasubramanian - Chairman, S Krishnan - Director, S Yuvaraj - Director, Nagaraj Garla - Nominee Director. 

It is listed on the BSE with a BSE Code of 524372 and the NSE with an NSE Code of ORCHIDCHEM.

Its Registered office is at ''Orchid Towers' ,' 313, Valluvar Kottam High Road,,Nungambakkam Chennai (Madras),Tamil Nadu - 600034.

Their Registrars are Integrated Enterprises (India) Ltd.

Company Information :- 

REGISTERED OFFICE :-

Address :''Orchid Towers' ,' 313, 

Valluvar Kottam High 

Road,,Nungambakkam

City  Chennai (Madras)

State Tamil Nadu

Pin Code 600034

Tel. No. 044-28211000

Fax No. 044-28211002

Email: corporate@orchidpharma.com

Internet http://www.orchidpharma.com

REGISTRARS

Name    Integrated Enterprises 
                   (India) Ltd.

Address  1st Floor, Kences 
               Towers, 

                No. 1, Ramakrishna 
                
                Street, North 

                Usman Road, T Nagar

                City  Chennai (Madras) -                  
                600017

                State Tamil Nadu

Tel. No. 044-28143045, 28143046,

 24345193, 28140801, 281408

Fax No. 044-28144826, 28140652

Email: corpserv@iepindia.com


Internet : http://www.iepindia.com

Orbit Corp Call

Orbit Corporation

  BSE: 532837 | NSE: ORBITCORP | ISIN: INE628H01015 | SECTOR: CONSTRUCTION & CONTRACTING - REAL ESTATE

**Medium Term Call**

Medium term call- 12-03-2015; investors with very high risk appetite looking for quick bucks can now buy Orbit Corporation ( Medium term)@ 14.20-12 sl 10 

tgt1  30.25

  tgt2  35 ! !

ABOUT ORBIT CORP :-

Orbit Corp is in the Construction & Contracting - Real Estate sector. The current market capitalisation stands at Rs 163.54 crore.The company has reported a consolidated sales of Rs 32.98 crore and a Net Loss of Rs -32.89 crore for the quarter ended Jun 2014.


The company management includes Ravi Kiran Aggarwal - Executive Chairman, Pujit Aggarwal - Managing Director & CEO, Abdul Mohammad Sattar - Independent Director, Urvashi Saxena - Independent Director.

It is listed on the BSE with a BSE Code of 532837 and the NSE with an NSE Code of ORBITCORP.

Its Registered office is at The View, 1st Floor,,165, Dr. Annie Besant Road, Mumbai,Maharashtra - 400018.

Their Registrars are Link Intime India Pvt. Ltd.

Company Information :- 

Registered Office:-

AddressThe View, 1st Floor,,165, Dr. Annie Besant Road,

CityMumbai

StateMaharashtra

Pin Code400018

Tel. No.022-30446910

Fax No.022-24911028

Email:info@orbitcorp.com

Internethttp://www.orbitcorp.com

Registrars :-

NameLink Intime India Pvt. Ltd.

AddressC-13, Pannalal Silk Mill Compound, LBS Marg, Bhandup (West)

CityMumbai - 400078

StateMaharashtra

Tel. No.022-25960320

Fax No.022-25960329

Email:rnt.helpdesk@linkintime.co.in

Internethttp://www.linkintime.co.in

Management:-

Ravi Kiran Aggarwal             -Executive Chairman

Pujit AggarwalManaging       -Director & CEO

Abdul Mohammad Sattar      -Independent Director

Urvashi Saxena                     -Independent Director  

Lotus Eye Care Call

Lotus Eye Care Hospital

                    BSE: 532998 | NSE: LOTUSEYE | ISIN: INE947I01017 | SECTOR: HOSPITALS & MEDICAL SERVICES

**Medium Term Call**

Medium Term Call; 10-03-2015 , Investors with very high risk appetite looking for quick bucks can now buy Lotus Eye Care(Medium Term)@15.55-13 
sl 10 
tgt1 23 
tgt2 25 !!

ABOUT LOTUS EYE CARE :-

Lotus Eye Care is in the Hospitals & Medical Services sector. The current market capitalisation stands at Rs 32.32 crore.The company has reported a standalone sales of Rs 7.80 crore and a Net Loss of Rs -0.29 crore for the quarter ended Dec 2014.

The company management includes S K Sundaramoorthy - Chairman & Managing Director, D R Kaarthikeyan - Director, S S Badrinath - Director, Yogesh Shah - Director, R Subramanian - Director, Kavetha Sundaramoorthy - Alternate Director, Sangeetha Sundaramoorthy - Director, G R Karthikeyan - Director, M Alagiriswamy - Director. 

It is listed on the BSE with a BSE Code of 532998 and the NSE with an NSE Code of LOTUSEYE.

Its Registered office is at S.F No.770/12, Avinashi Road,,Civil Aerodrome Post Coimbatore,Tamil Nadu - 641014.

Their Registrars are SKDC Consultants Ltd.

JP Associates Call

Jaiprakash Associates

                         BSE: 532532 | NSE: JPASSOCIAT | ISIN: INE455F01025 | SECTOR: INFRASTRUCTURE -GENERAL

**Medium Term Call**

Medium term call- 04-03-2015; investors with risk appetite looking for quick bucks can now buy JP Associates ( Medium term)@27.45-23 sl 19.90 
tgt1 46 
tgt2 50!!

About Jaiprakash Asso

Jaiprakash Asso is in the Infrastructure - General sector. The current market capitalisation stands at Rs 7,054.13 crore.The company has reported a standalone sales of Rs 2,557.81 crore and a Net Loss of Rs -116.09 crore for the quarter ended Dec 2014.

The company management includes Manoj Gaur - Executive Chairman & CEO, Sunil Kumar Sharma - Executive Vice Chairman, Sarat Kumar Jain - Vice Chairman, Sunny Gaur - Managing Director, Pankaj Gaur - Joint Managing Director, S C Rathi - Nominee Director, R N Bhardwaj - Independent Director, S C Bhargava - Independent Director, Homai A Daruwalla - Independent Director, B K Goswami - Independent Director, K N Bhandari - Independent Director, Ranvijay Singh - Whole Time Director, Rahul Kumar - WholeTime Director & CFO, K P Rau - Independent Director, SCK Patne - Independent Director, C P Jain - Independent Director, Shiva Dixit - Director, T R Kakkar - Independent Director.

It is listed on the BSE with a BSE Code of 532532 and the NSE with an NSE Code of JPASSOCIAT.

Its Registered office is at Sector - 128 , Noida,Uttar Pradesh - 201304.


Their Registrars are Alankit Assignment Ltd.

NMDC

NMDC

                      BSE: 526371 | NSE: NMDC | ISIN: INE584A01023 | SECTOR: MINING & MINERALS

About:-

NMDC is in the Mining & Minerals sector. The current market capitalisation stands at Rs 51,739.54 crore.The company has reported a standalone sales of Rs 2,944.39 crore and a Net Profit of Rs 1,593.01 crore for the quarter ended Dec 2014.

The company management includes Narendra Kothari - Chairman & Managing Director, N K Nanda - Director - Technical, S Thiagarajan - Director - Finance, Rabindra Singh - Director - Personnel, Vinod Kumar Thakral - Nominee Director, Syedain Abbasi - Nominee Director, Noor Mohammad - Independent Director, Vinai Kumar Agarwal - Independent Director, Mahesh Shah - Independent Director, T R K Rao - Vice Chairman & Mng.Director, P K Satpathy - Director - Production, Pradip Kumar Satpathy - Director - Production, S Thiagarajan - Director - Finance, Subimal Bose - Director - Production, Rabindra Singh - Director - Personnel, Noor Mohammad - Director, Vinai Kumar Agarwal - Director, Mahesh Shah - Director, Syedain Abbasi - Director, Narendra Kothari - Chairman & Managing Director, S J Sibal - Director, N K Nanda - Director - Technical. 

It is listed on the BSE with a BSE Code of 526371 and the NSE with an NSE Code of NMDC.

Its Registered office is at "Khanij Bhavan", 10-3-311/A,,Castle Hills, Hyderabad,Telangana - 500028.

Their Registrars are Aarthi Consultants Pvt Ltd

Operating Profit & OPM

Operating Profit gives an indication of the current operational profitability of the business and allows a comparison of profitability between different companies after removing out expenses that can obscure how the company is really performing.

Interest cost depends on the management's choice of financing, tax can vary widely depending on acquisitions and losses in prior years, and depreciation and amortization policies may differ from company to company.

EBITDA, PBT & PAT:-

EBITDA is an acronym for Earnings Before Interest, Taxes, Depreciation, and Amortization. PBT stands for Profit Before Tax, and PAT stands for Profit After Tax.

The graph visually shows how the net profit of the company stand reduced due to the impact of Interest, Depreciation, and Tax.

Net Sales:

Sales is the total amount of products or services sold by the company.

Recent News and Activities :-

• Mar 03, 2015
  Iron ore prices cut by Rs 300-550/tn on weak demand: NMDC

• Mar 04, 2015
  International iron ore prices showing signs of softening: NMDC 

We have to be positive only if this company performance is good. China is one and only largest manufacturer of iron ore. Their growth data released yesterday its not good.

To increase their economy, china will sell ore at any cost, that will affect NMDC near future. NMDC will be forced to reduce ore price further. This week this stock will trade 130, next week 120. Ones if we enter into this stock at 120 price level, we can make good money thru dividend.

Conclusion:-

Based on the fact that Iron ore and other commodity prices will continue to slide in 2015 as per world body, Therefore at present, all investors must step back from investing in this script. It will be beneficial to us if we enter into it few days after consolidation. 

Zenotech Labs

Zenotech Laboratories

(BSE:532039)

CMP: 29.75

This small company with a market cap of under 100 crores is looking like a "NOTHING" till today, It has losses it has debt and it has closed its manufacturing unit.But the point here is: This company is owned by Ranbaxy Laboratories and Daichii Sankyo.Ranbaxy holds 46.84%, Daiichi Sankyo holds 20% that is 66.84% promoter holding. Its ex-promoters (Chigurupati family) from whom Daiichi had acquired the shares is still holding more than 20% stake. Which means a total of 86.84% is with ex and present promoters.Now with the Sun Pharma - Ranbaxy deal, Sun Pharma becomes the owner of this small company and it also made a mandatory open offer last year to acquire Daiichi Sankyo's 20% in Zenotech at Rs 18 per share but now the open offer price will be needed to change according to SEBI regulations.Chigurupati did not want to sell his shares under 160 rs per share and yet Daiichi managed to acquire the company but till date the case is going on.

I think it is mandatory for Sun Pharma to make the open offer and acquire the company fully. Via Ranbaxy, Sun Pharma already owns 46.84% and by buying additional it will further increase Sun Pharma's holding in Zenotech.

Now what about the future? Either, Sun Pharma can buy Chigurupati's stake too and delist the company or else Sun Pharma may start the operations for this company, In any case Chigurupati will not be easy to deal with as his earlier case against Daiichi is still stretched up.Sun Pharma is on a acquisition drive, Last week it has purchased opiates manufacturing unit of Glaxo in Australia.

I think Sun Pharma will takeover Zenotech and starts its operation too but this is a pure assumption, Company is not in good health.

I think this can be the next "KREBS BIO" which is another shut down company being taken over by IPCA Laboratories which has moved the share price from 30s in Feb 2015 to almost 100 today.Disclaimer: I may have vested interest in this stock.

Note: This is not a recommendation, Exercise caution.

Operating Profit and OPM

EBITDA

(Earnings Before Interest, Taxes, Depreciation, and Amortization)